Source: White House finds Pelosi drug plan ‘unworkable’
President Trump is instead backing a bipartisan bill that would for the first time limit what seniors have to pay out of their own pockets for medications.
Pharmaceutical
Articles
Walgreens to close in-store clinics, add Jenny Craig sites
The company said Monday that it will close 150 Walgreens-run clinics by the end of the year, but it will keep open more than 200 that are run in partnership with health care providers.
Eli Lilly CEO says drugmaker won’t rehash old Alzheimer’s data
Digging through old data to salvage a seemingly failed Alzheimer’s drug paid off big time for Biogen Inc., but at least one of its rivals has no plans to follow suit.
Trump, Pelosi still working on drug-pricing deal despite impeachment drama
President Donald Trump and House Speaker Nancy Pelosi could hardly be more at odds—but behind the scenes, they’re still grasping at a bipartisan deal to lower the cost of prescription drugs.
Lilly earns more than expected but misses revenue expectations on key drugs
Eli Lilly and Co. easily topped earnings expectations in the third quarter, but shares in the Indianapolis-based drug company tumbled nearly 5 percent Wednesday morning.
Indiana sues distributors in opioid epidemic
One day after three opioid distributors reached a $260 million tentative settlement with two Ohio counties, Indiana Attorney General Curtis Hill filed a lawsuit seeking damages from the same three companies.
In surprise turnaround, new analysis finds Alzheimer’s treatment might work
Seven months after clinical trials for a promising Alzheimer’s drug were halted and the treatment was declared a failure, a new analysis suggests it was actually effective, and the company that makes it plans to move forward in securing federal approval.
Nation’s top drug distributors reach $260M deal to settle opioids lawsuit
The settlement means a high-profile trial in Ohio will not move forward, but it does not resolve more than 2,600 other lawsuits across the country seeking to hold the drug industry accountable for a crisis that has been linked to more than 400,000 U.S. deaths since 2000.
Opioid settlement talks broaden ahead of first federal trial
Outlines of a settlement call for $22 billion in cash over time plus up to $15 billion worth of overdose antidotes and treatment drugs, with distribution of those drugs valued at another $14 billion.
Lilly experimental drug fails in late-stage trial for pancreatic cancer
The drug, called pegilodecakin, had been seen as a promising treatment for one of the deadliest types of cancer, and was the lead product in Lilly’s $1.6 billion acquisition of Armo BioSciences last year.
VP Pence says Indiana has ‘a lot to gain’ from new North American trade deal
Vice President Mike Pence stumped for President Trump’s proposed deal with Mexico and Canada during a rally Thursday at McAllister Machinery on the city’s southeast side.
Pace planning 200-acre life-science business park by airport
The owner of Pace Air Freight, which specializes in truck transport of pharmaceutical products, is in the process of assembling land it doesn’t already own, including parcels owned by Indianapolis International Airport.
Indiana joins states seeking to settle with Purdue Pharma
Indiana Attorney General Curtis Hill is among the 29 attorneys general across the country backing a proposed settlement with OxyContin maker Purdue Pharma, calling the agreement a “significant breakthrough in our important fight against the opioid crisis.”
Pharmacy owner sentenced to 33 months for making over-potent drugs
Paul Elmer, 68, of Fishers, was sentenced Wednesday in U.S. District Court in Indianapolis, six months after a jury found him guilty of nine counts of adulterating compounded drugs and one count of conspiracy.
Opioid deal may set price for drug industry settlements
Purdue Pharma may have just set the starting point for determining what it will cost dozens of pharmaceutical companies to resolve legal liability over their role in creating the U.S. opioid epidemic.
Chaotic talks show challenge of reaching opioid settlement
By Thursday, half of the nation’s state attorneys general said they would reject a tentative deal crafted by the other half, and many criticized the terms as grossly insufficient.
UPDATE: Tentative opioids settlement falls short of nationwide deal
A tentative settlement announced Wednesday over the role Purdue Pharma played in the nation’s opioid addiction crisis falls short of the far-reaching national settlement the OxyContin maker had been seeking for months, with litigation sure to continue.
Lilly’s hot-selling Taltz approaching blockbuster status
Last year, Taltz rang up sales of $937.5 million, and doctors are increasingly prescribing it. For the first six months of this year, Taltz recorded $606.3 million in sales, putting it on pace to break the $1 billion threshold, perhaps in the third quarter.
Opioid settlement would divide money based on local impact
The formulas would take into account several factors, including opioid distribution in a given jurisdiction, the number of people who misuse opioids and the number of overdose deaths.
Doctors don’t always know what patients will owe for meds
While the price of almost any good or service can be found online, most Americans don’t know what they’ll owe for a prescription medication until they get it.